Ameliorated Pap Tests and Cervical Cancer Screening Participation

Recruiting now · Not applicable

Conditions studied: Cervical Cancer Screening, Cervical Cancer Screening Methods

In brief

The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation. The present project is the first multicenter randomized controlled trial to expand the current scope of the peak-end theory into Pap tests and cervical cancer screening participation by adding a non-painful step at the end of Pap smear screening. Our multidisciplinary team (NTUH Pap Study Group) aims to provide innovative, feasible, and low-cost strategies for cervical cancer screening participation.

Key facts

Study ID
NCT06968871
Run by
National Taiwan University Hospital
People needed
248
Starts
2026-03-01
Expected to finish
2032-12-31
Last updated by the study team
2026-03-03

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.